New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
IT
Archived
•
October 24, 2026
•
2 views
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Source: Wired | https://www.wired.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



